Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine(CanSino Biologics)

N/A

Report date: 2024/12/23 10:25:58

Base Information

Drug NameLyophilized Haemophilus Influenzae Type b Conjugate Vaccine(CanSino Biologics)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Conjugated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCanSino Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCanSino Biologics Inc
Inactive CompaniesN/A
Active IndicationsHaemophilus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A